North America Pharmacokinetics Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Pharmacokinetics Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Pharmacokinetics Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Pharmacokinetics Services Market Regional Analysis

6.2 North America Pharmacokinetics Services Market Revenue 2021-2031 (US$ Million)

6.3 North America Pharmacokinetics Services Market Forecast Analysis

7. North America Pharmacokinetics Services Market Analysis – by Drug Type

7.1 Small Molecule

7.1.1 Overview
7.1.2 Small Molecule: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Large Molecule

7.2.1 Overview
7.2.2 Large Molecule: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Vaccines

7.3.1 Overview
7.3.2 Vaccines: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Pharmacokinetics Services Market Analysis – by Service Type

8.1 Pre-Clinical ADME and Human Studies

8.1.1 Overview
8.1.2 Pre-Clinical ADME and Human Studies: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 PK/PD Analysis and Reporting

8.2.1 Overview
8.2.2 PK/PD Analysis and Reporting: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Dosing Simulations

8.3.1 Overview
8.3.2 Dosing Simulations: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Risk Analysis

8.4.1 Overview
8.4.2 Risk Analysis: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Pharmacokinetics Services Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Contract Research Organization

9.2.1 Overview
9.2.2 Contract Research Organization: North America Pharmacokinetics Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Pharmacokinetics Services Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Pharmacokinetics Services Market Breakdown, by Key Country, 2024 and 2031 (%)
10.2.1.1 North America Pharmacokinetics Services Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.1.1 US: North America Pharmacokinetics Services Market Breakdown, by Drug Type
10.2.1.1.2 US: North America Pharmacokinetics Services Market Breakdown, by Service Type
10.2.1.1.3 US: North America Pharmacokinetics Services Market Breakdown, by End User

10.2.1.2 Canada: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.2.1 Canada: North America Pharmacokinetics Services Market Breakdown, by Drug Type
10.2.1.2.2 Canada: North America Pharmacokinetics Services Market Breakdown, by Service Type
10.2.1.2.3 Canada: North America Pharmacokinetics Services Market Breakdown, by End User

10.2.1.3 Mexico : North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.3.1 Mexico : North America Pharmacokinetics Services Market Breakdown, by Drug Type
10.2.1.3.2 Mexico : North America Pharmacokinetics Services Market Breakdown, by Service Type
10.2.1.3.3 Mexico : North America Pharmacokinetics Services Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Charles River Laboratories International Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Eurofins Scientific SE

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Evotec SE

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Certara Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Parexel International Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Thermo Fisher Scientific Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Allucent

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 PACIFIC BIOLABS

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 SGS SA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Pharmacokinetics Services Market